Medicare spending on medical imaging continues to decline and that Medicare patients are receiving fewer imaging procedures, according to a new analysis of Medicare data released Nov. 17 by the Medical Imaging & Technology Alliance (MITA).
Medicare spending on medical imaging continues to decline, and Medicare patients are receiving fewer imaging procedures, according to a new data analysis released this week by the Medical Imaging & Technology Alliance (MITA).
The MITA analysis found that spending on imaging services for each Medicare beneficiary has fallen 13.2 percent since 2006, when significant imaging-specific reimbursement cuts from the Deficit Reduction Act took effect. Imaging utilization per beneficiary declined by 3 percent in 2010.
Spending for non-imaging Medicare services has grown by 20 percent since 2006 and utilization increased 2 percent in 2010, MITA found.
“This analysis confirms the downward trend in both imaging spending and utilization in Medicare that has occurred in recent years. The assumption that life-saving diagnostic imaging and radiation therapy are increasing health care costs is simply not true,” said David Fisher, executive director of MITA.
The analysis also found that imaging is now a smaller portion of Medicare spending than it was a decade ago.
Congress and the Administration have cut imaging reimbursements seven times in six years, with payments for some services being reduced by more than 60 percent, including bone density screenings, arm and leg artery X-rays, and MRIs of the brain, MITA said.
“Current evidence, including this analysis, debunks the myth that imaging is significantly overused and somehow responsible for escalating healthcare costs. Unlike other areas of medicine, imaging utilization and spending are on the decline,” said John A. Patti, MD, chairman of the American College of Radiology Board of Chancellors. “According to these data, the goal of bending the cost curve has indeed been achieved for medical imaging. Any further reductions would represent socially irresponsible policy.”
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.